Observational studyBMC public health2025
Association between depressive symptoms and thyroid nodule incidence in women: a prospective observational study.
Observational study in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study aimed to investigate the association between depressive symptoms and the incidence of thyroid nodules (TNs) in Chinese adults, and explore whether the development, persistence, or recovery from depressive symptoms influences the risk of developing TNs.
methodsA total of 1,537 Chinese adults who underwent medical check-ups, including blood tests, Zung Self-Rating Depression Scales (SDS), and thyroid ultrasound examinations, were included. The association between depressive symptoms and TN prevalence was evaluated, and 818 participants free of TNs at baseline were followed over time. TN incidence rates were analyzed across different mental health statuses: depression-free, depression-developed, depression-recovered, and depression-persistent.
resultsThe prevalence of depressive symptoms was 31.95%, significantly higher in women than in men (42.60% vs. 25.82%). The prevalence of TNs was also higher in women (38.68% vs. 21.52%). Among women, participants with depressive symptoms had shorter height, higher levels of fasting plasma glucose (FPG), triglycerides (TG), and glutamyl transpeptidase (GGT), lower high-density lipoprotein cholesterol (HDL-C), and a significantly higher prevalence of TNs (46.44% vs. 32.92%, p < 0.01) compared to those without depressive symptoms. Although the FPG levels in depressive women were significantly higher than in non-depressive women, the levels of FPG in both groups remained within the clinically normal range. These differences were not observed in men. Over a mean follow-up of 2.75 years in women, the depression-persistent group (16.48/100 person-years) had a significantly higher TN incidence compared to the depression-free (6.43/100 person-years; age-adjusted HR: 2.679, 95% CI: 1.513-4.742, p = 0.001).
conclusionsWomen with persistent depressive symptoms had a higher risk of developing TNs, suggesting that mental health status may influence TN development in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.